Holen Sie sich die Stockscreener-App
0.514
7.04%
0.0338
Schlusskurs vom Vortag:
$0.4802
Offen:
$0.4706
24-Stunden-Volumen:
2.03M
Relative Volume:
0.26
Marktkapitalisierung:
$5.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0889
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
+13.92%
1M Leistung:
+108.94%
6M Leistung:
-47.45%
1J Leistung:
-56.07%
1-Tages-Spanne:
$0.4651
$0.52
1-Wochen-Bereich:
$0.3513
$0.5248
52-Wochen-Spanne:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Vergleichen Sie ADIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.514 | 7.58M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals Inc. Stock Analysis and ForecastHigh-profit trading signals - PrintWeekIndia
What drives Adial Pharmaceuticals Inc. stock priceBreakthrough stock performance - PrintWeekIndia
Why Adial Pharmaceuticals Inc. stock is on top investor watchlistsAccelerated capital growth - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
What analysts say about Adial Pharmaceuticals Inc. stockExtraordinary profit generation - PrintWeekIndia
Published on: 2025-07-24 22:20:15 - jammulinksnews.com
Autolus Therapeutics Soars 10.79% on EU Approval of AUCATZYL - AInvest
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Adial Pharmaceuticals Regains Nasdaq Compliance After Offering - TipRanks
Adial Pharmaceuticals (ADIL) Regains Nasdaq Compliance | ADIL St - GuruFocus
Adial Pharmaceuticals regains Nasdaq compliance after equity offering By Investing.com - Investing.com South Africa
Adial Pharmaceuticals regains Nasdaq compliance after equity offering - Investing.com
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement - GlobeNewswire
Adial Pharmaceuticals Secures Future on Nasdaq: Key $2.5M Equity Requirement Achieved - Stock Titan
How Adial Pharmaceuticals Inc. stock performs during market volatilityReal Time Breakout Tracking - Newser
What makes Adial Pharmaceuticals Inc. stock price move sharplyBreakout Level Watch - Newser
Why Adial Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):